Study: Ibuprofen cuts Parkinson’s risk

Wednesday, March 2, 2011 - 16:30 in Health & Medicine

A new study by Harvard School of Public Health (HSPH) researchers shows that adults who regularly take ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), reduce their risk of developing Parkinson’s disease by about one-third compared with nonusers. “There is no cure for Parkinson’s disease, so the possibility that ibuprofen, an existing and relatively nontoxic drug, could help protect against the disease is captivating,” said senior author Alberto Ascherio, professor of epidemiology and nutrition at HSPH. The study will be published online March 2 in Neurology and is scheduled to appear in the March 8 print issue. Parkinson’s disease, a progressive central nervous system disease occurring generally after age 50, affects at least half a million Americans, according to the National Institute of Neurological Disorders and Stroke. About 50,000 new cases are reported each year, with the number expected to increase as the U.S. population ages. It is hypothesized that ibuprofen may reduce inflammation in...

Read the whole article on Harvard Science

More from Harvard Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net